Therefore, the current study aims to comprehensively and quantitatively analyze available data to evaluate the effect of statins on CIMT progression and CRP in T2DM and to rule out any inconsistencies observed in previous clinical evidence. Here, CRP is linked to type 2 diabetes mellitus.